Information
-
Trademark
-
79392996
-
International Classifications
-
Filing Date
December 19, 2023
5 months ago
-
Transaction Date
April 18, 2024
a month ago
-
Status Date
April 04, 2024
2 months ago
-
Location Date
April 04, 2024
2 months ago
-
Status Code
630
-
Current Location
INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM)
-
-
Owners
Mark Drawing Code
4000
Mark Identification
BDC
Case File Statements
- GS0051: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical products and preparations for use in relation to oncology; pharmaceutical products and preparations for use in relation to ophthalmology; pharmaceutical products and preparations for use in relation to neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease
- GS0421: Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical research and development services; medical research and development services; pharmaceutical testing and clinical trials; clinical trials; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; information consultancy and advisory services relating to the aforesaid
Case File Event Statements
-
4/18/2024 - a month ago
3 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
4/12/2024 - a month ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
4/4/2024 - 2 months ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR